Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.
about
Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococciCase-case-control study on factors associated with vanB vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia.Risk of postdischarge infection with vancomycin-resistant enterococcus after initial infection or colonizationAcquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type.Functional disability and nursing resource use are predictive of antimicrobial resistance in nursing homesClinical characteristics and risk factors of enterococcal infections in Nagasaki, Japan: a retrospective study.Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapyGlobal variances in infection control practices for vancomycin resistant Enterococcus - results of an electronic survey.Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipient.Vancomycin-resistant Enterococcus faecium Bacteremia in a tertiary care hospital: epidemiology, antimicrobial susceptibility, and outcome.Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.The prevention and management of infections due to multidrug resistant organisms in haematology patientsVancomycin-resistant enterococcal bacteremia pharmacotherapy.The challenge of antibiotic resistance in haematology patients.Integrating Time-Varying and Ecological Exposures into Multivariate Analyses of Hospital-Acquired Infection Risk Factors: A Review and Demonstration.Evaluation of a chromogenic agar under development to screen for VRE colonization.Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital.Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation.Vancomycin-resistant enterococci in acute myeloid leukemia and myelodysplastic syndrome patients undergoing induction chemotherapy with idarubicin and cytarabine.Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.Results of Four-Year Rectal Vancomycin-Resistant Enterococci Surveillance in a Pediatric Hematology-Oncology Ward: From Colonization to Infection.Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing.Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy.Driving forces of vancomycin-resistant E. faecium and E. faecalis blood-stream infections in children.Vancomycin-resistant enterococci infection: not just for the transplanted.Recent increase in enterococci, viridans streptococci, Pseudomonas spp. and multiresistant strains among haematological patients, with a negative impact on outcome. Results of a 3-year surveillance study at a single institution.Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study.Clinical features and outcomes of bacteremia caused by Enterococcus casseliflavus and Enterococcus gallinarum: analysis of 56 cases.A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price?Comparative cost-effectiveness of alternative empiric antimicrobial treatment options for suspected enterococcal bacteremia.Prevalence of and risk factors for colonization with vancomycin-resistant enterococcus among human immunodeficiency virus-positive outpatients.Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients.A population-based investigation of invasive vancomycin-resistant Enterococcus infection in metropolitan Atlanta, Georgia, and predictors of mortality.Vancomycin-resistant enterococci colonization-infection model: parameter impacts and outbreak risks.Duration of exposure to multiple antibiotics is associated with increased risk of VRE bacteraemia: a nested case-control study.Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk
P2860
Q33258506-0644421E-EF28-43CF-A34A-C100882C4D80Q33880518-E3277C11-AA27-4B9F-9F81-F3CB122B1BCBQ34786232-8C890E9D-4192-4B06-AA02-1945F836BAD3Q34948456-83B31E3C-5ABE-4D38-AA90-880B5C9098FEQ35528067-07E853A5-9CC9-4FC5-A69C-B66A073BEC78Q35809439-4CD84A74-1737-424B-818A-EC911DD4C41DQ36382134-40DE6EF2-7D49-4431-AF69-FE898167183DQ36932977-389CF260-8465-4AAA-B87E-78A1EF015E50Q37390931-8CDA68B4-AF05-425E-8443-2EF9FF442205Q37421260-2DE7362A-D4A7-479C-8129-78BFED3F625DQ37657769-C7B0F0B8-3E4E-478A-AECA-147C9B905AE4Q38126225-07594012-3274-420B-A78B-E2D1A1808272Q38171538-803D4196-D093-478D-8CD5-FC8B06B58520Q38263421-87A80F74-0507-4A14-B099-3875B6FED9D8Q38613929-7F86983D-196E-4B44-A76F-900EEB133536Q38734907-AA2C3C99-68A6-4C11-BDB7-86F6885B18B5Q39413092-180DF368-CA30-42E6-A634-AB6F9CEDFFEDQ39910428-3544DF73-B3D2-45D4-B644-95305EE3CA5CQ40041299-639D3C7F-E636-4B18-912E-DCC0D361266EQ40199386-F19BF26E-FCF3-42E4-9813-D7149030D51FQ40267813-2DAC2C4D-0336-4CF1-A414-711DC1A9B5A6Q40274934-7E6B4D0E-F655-4763-A85B-071A502B07F0Q40284635-2415A93E-5B5E-42D0-B8A4-F4BE5F61BEC6Q40707661-DDAA70B6-DE20-43C3-B3D2-26F303D39CFDQ40957598-E4B8FA9E-D765-4C23-A006-AF0A3C821F54Q41560706-CED55CAA-48A1-49CE-B335-22A395972958Q41745236-7A5AA12F-45AB-48E6-834C-DE2B89C9E54CQ42248187-A6997A0C-C487-4672-9DAF-8BCC00270485Q43184611-94F878CF-8E5E-4AAE-A19A-A12812DDB8FFQ43984868-53352BE3-F943-435F-AD97-2389708CBAD8Q44696137-30042258-518F-464E-AD08-B352ABDC0001Q44930328-D4B6AA42-9FD3-4C89-9AFC-9DFA389E34E3Q45013453-6281A10C-741D-4A7D-9977-6636A4C08F03Q45419001-1EBCFFFE-15B4-46E5-8856-9A4C10A6C1B9Q46639421-DD248E3A-4651-4980-960C-46D4C4CA59C2Q46847070-F67B5BBE-A93B-432A-8193-3BACDA94855FQ46914675-80AACB30-B2CA-45EA-ACFC-F3723EC78E92Q51335728-D49FB733-5A0A-49E3-9645-F0528B17EB5FQ52651956-C7E0D6D4-6EE9-43D1-B314-3C6ECF7EA39DQ57746313-4339E082-FAFE-4A6F-8CF0-5890E02BE739
P2860
Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Risk factors for development o ...... comycin-resistant enterococci.
@en
Risk factors for development o ...... comycin-resistant enterococci.
@nl
type
label
Risk factors for development o ...... comycin-resistant enterococci.
@en
Risk factors for development o ...... comycin-resistant enterococci.
@nl
prefLabel
Risk factors for development o ...... comycin-resistant enterococci.
@en
Risk factors for development o ...... comycin-resistant enterococci.
@nl
P2860
P356
P1476
Risk factors for development o ...... ncomycin-resistant enterococci
@en
P2093
Aimee K Zaas
Pamela Tucker
P2860
P304
P356
10.1086/342904
P407
P577
2002-10-17T00:00:00Z